EGR1 c.851_852delinsAA ;(p.P284Q)

Variant ID: 5-137802989-CT-AA

NM_001964.2(EGR1):c.851_852delinsAA;(p.P284Q)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition.

Molecular & Cellular Proteomics : Mcp
Schmitt, Marisa M; Sinnberg, Tobias T; Bratl, Katrin K; Zittlau, Katharina K; Garbe, Claus C; Macek, Boris B; Nalpas, Nicolas C NC
Publication Date: 2021-10-19

Variant appearance in text: 225: P284Q
PubMed Link: 34673281
Variant Present in the following documents:
  • mmc2.xlsx, sheet 6
View BVdb publication page



Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition.

Molecular & Cellular Proteomics : Mcp
Schmitt, Marisa M; Sinnberg, Tobias T; Bratl, Katrin K; Zittlau, Katharina K; Garbe, Claus C; Macek, Boris B; Nalpas, Nicolas C NC
Publication Date: 2021

Variant appearance in text: 225: P284Q
PubMed Link: 34673281
Variant Present in the following documents:
  • mmc2.xlsx, sheet 6
View BVdb publication page



In vivo evolution of an emerging zoonotic bacterial pathogen in an immunocompromised human host.

Nature Communications
Launay, A A; Wu, C-J CJ; Dulanto Chiang, A A; Youn, J-H JH; Khil, P P PP; Dekker, J P JP
Publication Date: 2021-07-23

Variant appearance in text: 225: P284Q
PubMed Link: 34301946
Variant Present in the following documents:
  • 41467_2021_24668_MOESM4_ESM.xlsx, sheet 1
  • 41467_2021_24668_MOESM9_ESM.xlsx, sheet 9
View BVdb publication page